Fonte: PLOS ONE. Unidade: FMRP
Assuntos: HANSENÍASE, MYCOBACTERIUM LEPRAE, REAÇÃO EM CADEIA POR POLIMERASE, FATORES DE RISCO, EDUCAÇÃO EM SAÚDE, BIOMARCADORES, DOENÇAS TRANSMISSÍVEIS
ABNT
SILVA, Moises Batista da et al. Latent leprosy infection identified by dual RLEP and anti-PGL-I positivity: implications for new control strategies. PLOS ONE, v. 16, n. 5, p. 1-15, 2021Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0251631. Acesso em: 18 nov. 2024.APA
Silva, M. B. da, Li, W., Bouth, R. C., Gobbo, A. R., Messias, A. C. C., Moraes, T. M. P., et al. (2021). Latent leprosy infection identified by dual RLEP and anti-PGL-I positivity: implications for new control strategies. PLOS ONE, 16( 5), 1-15. doi:10.1371/journal.pone.0251631NLM
Silva MB da, Li W, Bouth RC, Gobbo AR, Messias ACC, Moraes TMP, Jorge EVO, Barreto JG, Bernardes Filho F, Conde GAB, Frade MAC, Salgado CG, Spencer JS. Latent leprosy infection identified by dual RLEP and anti-PGL-I positivity: implications for new control strategies [Internet]. PLOS ONE. 2021 ; 16( 5): 1-15.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1371/journal.pone.0251631Vancouver
Silva MB da, Li W, Bouth RC, Gobbo AR, Messias ACC, Moraes TMP, Jorge EVO, Barreto JG, Bernardes Filho F, Conde GAB, Frade MAC, Salgado CG, Spencer JS. Latent leprosy infection identified by dual RLEP and anti-PGL-I positivity: implications for new control strategies [Internet]. PLOS ONE. 2021 ; 16( 5): 1-15.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1371/journal.pone.0251631